Senators Join Critics Of ONDCP Program

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

‘This bill reflects a concern about how the program has been managed in the past.’

WASHINGTON The draft of a Senate bill that would oust Ogilvy & Mather from the White House’s anti-drug media campaign and give the Partnership for a Drug-Free America as much control over strategy as the Office of National Drug Control Policy is the latest sign that lawmakers intend to rein in an effort they feel has run amok, congressional and other sources said.

“This bill reflects a concern about how the program has been managed in the past,” one congressional source said.

The reauthorization bill—expected to be introduced this week—will have to be reconciled with a House version introduced in May that does not address Ogilvy’s role or the amount of creative control allocated to the Partnership.





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in